Incyte reports positive Phase 3 trial results for lymphoma drug

Markets Investing.com By Investing.com 13 Jun 2026 10:05 1 min read

Incyte reports positive Phase 3 trial results for lymphoma drug

Incyte reports positive Phase 3 trial results for lymphoma drug

Incyte reports positive Phase 3 trial results for lymphoma drug

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.